Mr. Pearson currently serves as both Chief Executive Officer and Chief Financial Officer for ASC Biosciences, Inc. and as a member of The Board of Directors.

Mr. Pearson gained over 45 years of financial and operational management experience with leading multinational corporations, such as John Mowlem & Co. PLC of London (by appointment to her Majesty the Queen) where, as Chief Accountant for the UK Construction Division, he was responsible for the financial management of more than 100 building and civil engineering projects including the Natwest Tower in the City of London Financial District, the London City Airport built in the East London Docklands area, as well as several thousand new homes in the “New Town” of Milton Keynes in Buckinghamshire.

Prior to this Mr. Pearson held the position of Financial Controller for the East Africa region for the Mowlem Group, based in Nairobi, Kenya, where the Mowlem Construction Company was engaged in many large civil engineering projects. As a regional Director, Mr. Pearson set up and managed semi-autonomous subsidiaries in Kenya, Tanzania, Zanzibar, Somalia, Ethiopia, Uganda and Sudan.

During almost a decade spent in East and Central Africa, Mr. Pearson also held senior financial management and accounting positions with Nchanga Consolidated Copper Mines in Kitwe, Zambia (a subsidiary of the Anglo-American Mining Company of South Africa), and the commercial vehicle division of Mercedes–Benz based in Lusaka, Zambia, a subsidiary of the conglomerate Lonrho Group PLC.

Mr. Pearson transferred from London to Beverly Hills in 1983 as Controller for British & Continental Development Corporation, a subsidiary of Burnett & Hallamshire, PLC. The Company was engaged in the acquisition and development of prime properties in Beverly Hills and the Westside of Los Angeles.

From 1988 through 1992 as Chief Financial Officer for Los Alisos Development Corporation in Orange County California, Mr. Pearson was instrumental in obtaining the entitlements to develop a 400 acre business park, “Pacific Commercentre” in Lake Forest, California.

From 1992 through 2010 Mr. Pearson was the Executive Vice President of American Realty Capital Advisors, a national real estate development capital placement firm, and CFO of several large and prestigious commercial and residential development companies in Southern California.  Mr. Pearson, who holds dual citizenship, is originally from Great Britain, and is a Fellow of the internationally recognized Association of Chartered Certified Accountants (ACCA) – one of only two U.K. professional accounting bodies authorized to audit the books of public corporations.

Mr. Pearson also holds a California Real Estate Broker’s License, and is enrolled to practice before the Internal Revenue Service.

Mr. Pearson a native of Yorkshire, England was educated at the Dewsbury Wheelwright Grammar School for Boys and the Foulks Lynch Accounting College in London. Mr. Pearson’s primary residence is in La Quinta, California which he shares with his wife Sharon.

Dr. Lucas is the Director of Orthopedic Research and an Associate Professor at the Department of Orthopedic Surgery New York Medical College and Westchester Medical Center, Valhalla, NY. He has a secondary appointment as Associate Professor in the Dept. of Pathology at New York Medical College.

Dr. Lucas has had an extensive career in academia and medical research. He’s considered a luminary in the field of stem cell sciences. From 1996 to 1997, he served as the chief scientist for Morphogen Pharmaceuticals and was a consultant for the Veterans Administration, at the Medical Center Castle Point. From 1989 to 1996, he served as the Director of Surgical Research and Associate Professor, Department of Surgery, Mercer University School of Medicine at the Medical Center of Central Georgia in Macon, GA. From 1987 to 1989, he was an Assistant Researcher at the Orthopedics Research Laboratories, University of California, Davis, CA. From 1986 to 1987, he was a Research Associate, Department of Biology at Case Western Reserve University in Cleveland, OH. From 1984 to 1985, he was a Postdoctoral Fellow with Dr. Arnold I. Caplan, Department of Biology at Case Western Reserve University. From 1981 to 1983, he was a Postdoctoral Fellow with Dr. Dominic D. Dziewiatkowski, Department of Oral Biology at the University of Michigan, Ann Arbor. Between 1974 and 1980, he performed his graduate work (Ph.D.) with Dr. Leon Singer, Department of Biochemistry, University of Minnesota, in Minneapolis.

Dr. Lucas received his B.A. in Chemistry from Macalester College in St. Paul, MN in 1974.

C.W. Gilluly has extensive experience in start-up, turnaround, high-growth companies and in negotiating terms and agreements for loans as a borrower.  Dr. Gilluly also has in-depth, hands-on experience with mergers and acquisitions, bankruptcy reorganizations and with corporate restructuring.

During the last 36 years, he has been the Chairman, CEO and/or President of three publicly traded companies and six privately held companies in industries ranging from high tech Internet information to federal government contracting to biological weapons defense. From June 1992, to June 2003, and from February 2004 to the January 2016, Dr. Gilluly served as a director and the Chairman of Comtex News Network, Inc. Originally a public company, that went private in June 2010, Comtex provides online, Internet delivered, electronic news and business information. From December 2003 until January 2007 he served as the President of Innovative Biologics, Inc., focused on searching for new anti-microbial drugs that target bacterial toxins. From January 2004 until September 2005 he served as President of Cameron Run Group, Inc., a company specializing in digital imaging technology. In November 2004, Dr. Gilluly was part of the team that facilitated a management buyout of Advanced Biosystems, Inc. (ABS), a division of publicly traded Analex Corporation.  He originally had helped to found ABS in 1999 to address defenses against Biowarfare and Bioterrorism.

ABS was subsequently renamed AFG Biosolutions, Inc. (AFG) and in August 2007 Dr. Gilluly and one of the other partners were bought out by the remaining partner. He was Chairman and CEO of Analex Corporation (formerly called Hadron, Inc.), headquartered in the Washington, D.C. area, from 1993 through 2000; additionally he was a director from 1993 to 2003. Analex (now dba Vencore, Inc.), was a publicly held company that specialized in developing innovative technical solutions for the intelligence community, analyzing and supporting defense systems (including intelligent weapons systems and biological weapons defense), and supporting complex computer systems for businesses and federal government agencies. Analex was sold to QinetiQ North America.  From January 1980 through March 1996, Dr. Gilluly was also the Chairman and CEO of Micro Research Industries, a leading provider of office automation systems to the U.S. House of Representatives.

He previously served on the Endowment Trust Board for St. Peter’s Catholic Church on Capitol Hill.  He formerly served as a Trustee of Western New England College, Springfield, Massachusetts from 1990 to 2002, and has previously served as a Director of two Washington, D.C. area banks.

From 1967 to 1976, Dr. Gilluly served as a naval pilot in the U.S. Pacific Fleet and is a veteran of the Vietnam War with 151 combat missions.  In 1976 he attended the Naval War College in Newport, Rhode Island, and from 1977 to 1979 he served as an Officer Strength Planner and a Senior Cost Analyst in the Economic Analysis section of the Chief of Naval Operations.  He separated from active duty in January 1980.

Besides his B.S. in Mechanical Engineering from Marquette University in Milwaukee, Wisconsin (1967), Dr. Gilluly holds an M.A. in Administration from Chapman College in Irvine, California (1974) and an Ed.D. (Doctorate in Educational Administration) from The Catholic University of America, in Washington, D.C. (1982).

He resides in Washington, D.C. with his wife, Marny. They both are senior members of the Military and Hospitaller Order of St. Lazarus of Jerusalem.  Dr. Gilluly is a Life Member of the Marquette University President’s Council, a Life Member of the Naval War College Foundation, a Lifetime Member of the Tailhook Association, a Lifetime Member of the Western New England University President’s Circle, and a Lifetime member of the Capitol Hill Club.

Advisory Board

Dr. Vigorita is a Diplomat, of the American Board of Pathology. He is currently Medical Director at Biomet Tissue Banks, Chairman Emeritus, Department of Pathology, Lutheran Medical Center, Brooklyn, NY, and Professor of Pathology and Orthopaedic Surgery at State University of New York Health Science Center Brooklyn, NY. He has been Medical Director of Lutheran Medical Center in Brooklyn, NY, and Chairman, of the Department of Pathology & Laboratory Medicine at Maimonides Medical Center, Brooklyn, NY, as well as having held numerous other distinguished positions. Dr. Vigorita is a distinguished researcher with over 85 peer-reviewed publications, three books, including “Orthopedic Pathology”, and several book chapters. Dr. Vigorita has worked on tissue engineering of meniscus using a collagen scaffold.

Dr. Grande, serves as Director of Orthopedic Research in the Department of Orthopedic Surgery at North Shore University Hospital and North Shore/LIJ Health System, Manhasset, NY. Dr. Grande also serves as the Director of Resident Research for the Department of Orthopedic Surgery.

He was a Research Associate in the Department of Bioengineering at the Hospital for Joint Diseases/Orthopedic Institute, NY.  Dr. Grande has served at Orthopaedic Research Laboratories at North Shore University Hospital since 1990.   He also serves as a Member of the Scientific Advisory Board of GeneNews Limited (formerly known as ChondroGene Ltd.) and TiGenix N.V.

Dr. Grande served as a Member of the Scientific Advisory Board of Cartilix, Inc. His dissertation was on the use of cartilage cells (chondrocytes) for transplantation to repair cartilage defects in the knee. Dr. Grande is also a mentor to high school, college, and medical students, who wish to pursue a career in orthopedics. He is the author of over 45 peer- reviewed publications in various scientific journals, considered a leader in the field of orthopedic tissue engineering, and is often invited to give presentations at prestigious conferences throughout the world. Dr. Grande has been honored with several awards for his contributions to the orthopedic field including the Charles S. Neer award in 2004. He has a Post- Doctoral Fellowship in Biomechanics at the Hospital for Special Surgery, NY and completed his Doctorate Training at New York University.

Dr. Julio Garcia graduated from Northwestern University in 1979 with a double major in Biology and Art History. He continued his education graduating from the University of Illinois, Chicago with his medical degree in 1983. He completed his training in Plastic Surgery at the University of Illinois in Chicago, serving his last two years as a Clinical Instructor of Surgery in 1988. He then went into the private practice of Plastic Surgery in Las Vegas, NV in 1988, where he has stayed for his entire career up to the present. Dr. Garcia was board certified by the American Board of Plastic Surgery in 1991, became Diplomat of the American College of Surgeons in 1993, and was certified by the American Board of Facial Plastic and Reconstructive Surgery in 1997. During his time in Las Vegas he has completed six medical missionary trips to Mexico to operate on indigent children with birth defects and two trips to the Philippines for the same. He is a published author in the Plastic and Reconstructive Surgery journal as well as in the Aesthetic Surgery Journal.

He lectures frequently to other plastic surgeons at national meetings.

Dr. Garcia is a consultant to the Harley Street Medical Park Wellness Center in Chennai, India where he provides supervisory assistance to the practicing physicians there in wellness medicine. Dr. Garcia’s practice in Las Vegas encompasses all aspects of aesthetic surgery, including surgical, non-surgical and injectable therapies, laser treatments and skin care. With Dr Garcia’s interest in wellness and patients, he has striven to keep up to date on all possible options. In early 2013, he began an affiliation with a network of over 20 clinics in the U.S. doing an IRB study to look at the potential of adipose derived stem cells. Through the utilization of this therapy for his patients, his personal interest in its potential grew as his desire to further extend the field of stem cell sciences. Dr. Garcia has sought out other leaders in the field to enhance this technology for the treatment and benefit of more patients.

Mr. Letovsky is the founder and CEO of Letovsky Dynamics, Inc. Mr. Letovsky is a successful inventor with fourteen issued patents including live human cell viability modification technology, fluorescent microscopy tools, missile defense systems, thermal differential engines that use shape memory alloys to generate power from ambient temperature changes, motion simulators for flight training and entertainment, virtual reality displays, and advanced slot machine gaming systems. His current patents pending include modulation of medical imaging system electromagnetic energy for therapeutic effects, space drive propulsion techniques, and radioactive waste neutralization systems.

His live cell viability modification system kills cancer cells without chemicals, and changes the molecular structure of cancer cells so they can no longer divide, and the immune system is alerted to their existence in the body. The technology is also designed to discover bioactive electrical stimuli to promote accelerated healing of damaged tissues and potentially reactivate stem cell functionality in adult differentiated cells. This live cell viability modification system is covered under patent # 8972264 that discloses an Electro Medical Tool Optimization System (additionally, Mr. Letovsky has other related patents pending).

Mr. Letovsky has pioneered pollution free energy systems and personal electric transportation systems. He was also one of the first electric vehicle builders in the L.A. area in the early 1980s, and has produced numerous freeway legal electric cars. Mr. Letovsky designed and built the world’s first Electric Police Car in 1992, which was featured on the Discovery Channel show “Beyond 2000”, drag racing and winning against a standard American police car. He has constructed dozens of cutting edge street legal and agricultural electric vehicles, the world’s first solar powered train, solar powered low speed electric vehicles, and a Plug-In Hybrid Mileage Enhancement systems that can integrate with any hybrid gas electric vehicle to increase mileage to 100 MPG. In the 1980s, he served on the Tri-Cities transportation board in Glendale, California.

Mr. Letovsky has worked with and/or consulted to MacDonnell Douglas, The US Navy, the FAA, the FBI, Carnegie Mellon Robotics Institute, Sarnoff Labs, Sony Corporation, Universal Studios, 20th Century Fox, all major video game companies, Station Casinos, and dozens of other research and entertainment entities. Though his primary focus has been hardware and software development, Mr. Letovsky brings to ASC Biosciences, Inc., over thirty years of experience in the development and protection of intellectual property rights.


Are you as excited as we are about what the future holds for stem cell therapy?
We invite you to keep up with our progress by subscribing to our newsletter.